The estrogen-dependent pathway activates the PI3K/AKT signalling process by directly binding to the p85α regulatory subunit of PI3K, thus enhancing the transcriptional activity of targeted genes in breast cancer cells [65]. This evidence concerns the gene AKT1 and breast cancer.